Total Funding
62
48
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
122478
NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.
Alan Ezrin: President & CEO- Alan Ezrin: Founder
About the Company
NX PharmaGen’s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company’s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield.
